- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07600229
Barefoot Walking VS Standardised Conservative Care for Plantar Fasciopathy
Clinical and Economic Effectiveness of Barefoot Walking Compared to Standardised Conservative Care for the Treatment of Plantar Fasciopathy: a Pragmatic Randomised Controlled Trial
The goal of this clinical trial is to learn if a barefoot walking programme can treat plantar fasciopathy (heel pain) in adults aged 18-70. The main questions it aims to answer are:
- Does a barefoot walking programme reduce heel pain compared to a standardised stretching and strengthening programme?
- Does a barefoot walking programme improve foot function and quality of life in adults with plantar fasciopathy?
Researchers will compare a barefoot walking programme to a standardised stretching and strengthening programme to see if barefoot walking is an effective conservative management approach for plantar fasciopathy.
Participants will:
- Be randomly assigned to either a barefoot walking programme or a stretching and strengthening programme
- Complete a 12-week home-based exercise programme
- Complete short weekly questionnaires throughout the 12 weeks
- Complete 3 follow-up surveys over 6 months after the intervention ends
- Receive education on load management and plantar fasciopathy
Tutkimuksen yleiskatsaus
Tila
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Carlow County
-
Carlow, Carlow County, Irlanti, R93 V960
- Rekrytointi
- South East Technological University
-
Ottaa yhteyttä:
- Elisabetta Brigo, PhD Researcher, MSc, BSc
- Puhelinnumero: +39 3450498301
- Sähköposti: c00315626@setu.ie
-
Päätutkija:
- Elisabetta Brigo, PhD Researcher, MSc, Bsc
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Aged 18-70 years;
- Clinical diagnosis of Plantar Fasciopahty, defined by: a) Pain localised to the medial calcaneal tubercle of sharp or stabbing quality; b) Pain worst with the first few steps in the morning or after a period of rest (first-step pain); c) Pain reproduced with palpation of the medial calcaneal tubercle OR positive Windlass Test;
- Symptom duration greater than 4 weeks;
- Able to walk independently without a mobility aid
- Able to provide informed consent and comply with study protocol
Exclusion Criteria:
- Prior surgery on the affected foot
- Diabetes with peripheral neuropathy or other neurological condition affecting lower limb sensation or motor control
- Active inflammatory arthropathy, uncontrolled vascular disease, or inability to walk unaided
- Current or recent (less than 6 months) bony stress fracture or other acute foot or ankle injury on the affected side
- Pregnancy during the intervention period
- BMI greater than 40 kg/m²
- Corticosteroid injection to the affected foot within the previous 3 months
- Night splints initiated less than 4 weeks prior to enrolment
- Any condition that would make participation unsafe, including open foot wounds
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Barefoot Walking
Participants allocated to this arm will follow a structured 12-week progressive barefoot walking programme on grass completed at home.
The programme involves gradually increasing the duration and frequency of barefoot walking on grass.
Participants will receive education on plantar fasciopathy, load management principles, and guidance on how to progress the programme safely.
Adherence and symptom response will be monitored through weekly short questionnaires.
|
A structured 12-week progressive home-based barefoot walking programme on grass for adults with plantar fasciopathy.
Participants gradually increase the duration and frequency of barefoot walking over the 12-week period.
Education on plantar fasciopathy and load management principles is provided.
Adherence and symptom response are monitored via weekly questionnaires.
Muut nimet:
|
|
Active Comparator: Standardised Conservative Care
Participants allocated to this arm will follow a structured 12-week standardised stretching and strengthening programme completed at home.
The programme includes plantar fascia and calf stretching exercises alongside progressive foot and lower limb strengthening exercises.
Participants will receive education on plantar fasciopathy and load management principles.
Adherence and symptom response will be monitored through weekly short questionnaires.
|
A structured 12-week standardised home-based stretching and strengthening programme for adults with plantar fasciopathy.
The programme includes plantar fascia and calf stretching alongside progressive foot and lower limb strengthening exercises.
Education on plantar fasciopathy and load management principles is provided.
Adherence and symptom response are monitored via weekly questionnaires
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
First-Step Pain
Aikaikkuna: From the baseline assessment (Week 0) until end of intervention (Week 12)
|
Changes in average first-step morning pain over the last 7 days measured with the Numeric Pain Rating Scale (NPRS), where 0 = no pain and 10 = worst imaginable pain.
|
From the baseline assessment (Week 0) until end of intervention (Week 12)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Adherence
Aikaikkuna: Weekly during the 12-week intervention period.
|
Percentage of prescribed home exercise sessions completed, recorded via participant self-report log throughout the 12-week intervention period.
|
Weekly during the 12-week intervention period.
|
|
Cost-Effectiveness (Incremental Cost-Effectiveness Ratio)
Aikaikkuna: At week 12 and at 6 months post-intervention (week 36).
|
Incremental cost per unit of clinical improvement between groups, expressed as cost per 1-point improvement in pain (NPRS) and cost per 10% improvement in foot function (FFI).
Total costs will include healthcare utilisation and participant out-of-pocket expenses.
Two separate ICERs will be calculated.
|
At week 12 and at 6 months post-intervention (week 36).
|
|
Adverse Events
Aikaikkuna: Throughout the 12-week intervention and at 2, 4, and 6 months post-intervention.
|
Any training-related injuries, falls, skin injuries, or symptom exacerbations reported by participants throughout the study period, recorded via weekly questionnaires and follow-up surveys.
|
Throughout the 12-week intervention and at 2, 4, and 6 months post-intervention.
|
|
Function
Aikaikkuna: From baseline (Week 0) until the end of intervention (Week 12)
|
Changes in foot function measured with the Foot Function Index (FFI).
Higher scores indicate worse function.
|
From baseline (Week 0) until the end of intervention (Week 12)
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- SETU/REC/25/26/050
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .